Status:
RECRUITING
Non-Invasive Portal and Hepatic Vein Pressure Estimation
Lead Sponsor:
Leiden University Medical Center
Conditions:
Portal Hypertension
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Background Portal hypertension (PH) is a spectrum of complications of end-stage liver disease (ESLD) and cirrhosis, with severe manifestations including ascites and gastroesophageal varices. It is the...
Eligibility Criteria
Inclusion
- Eligible for liver transplantation (LT) screening (which excludes pregnancy).
- Age ≥ 18 years and ≤ 75 (since \>75 is a contraindication for LT).
- Written informed consent.
Exclusion
- Exclusion criteria for MRI (claustrophobia, pacemaker, metal implants, etc.).
- A psychiatric, addictive or any other disorder that compromises the subjects ability to understand the study content and to give written informed consent for participation in the study.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06210178
Start Date
December 1 2023
End Date
December 1 2026
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center
Leiden, South Holland, Netherlands, 2333ZA